Repurposing Amlexanox to treat head and neck cancers: Increasing neoantigen expression to facilitate immunotherapy
Saved in:
Main Authors: | Saravanan Sekaran, Dhanraj Ganapathy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024001742 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor-grafted chorioallantoic membrane model: A versatile approach to study head and neck squamous cell carcinoma physiopathology and therapeutics testing
by: Saravanan Sekaran, et al.
Published: (2024-06-01) -
Increasing the neoantigen expression by nonsense mediated mRNA decay inhibitors: An effective therapeutic approach in oral cancer?
by: Saravanan Sekaran
Published: (2024-06-01) -
Pyrotinib: A promising therapeutic prospect for treating metastatic salivary gland cancer
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01) -
miR-1266-5p as a prognostic marker and miR-1255-5p/DAB2IP axis a therapeutic target in malignant transformation of oral submucous fibrosis
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01) -
Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)